What are the consequences of inadequate design or poorly conducted clinical trials?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What are the consequences of inadequate design or poorly conducted clinical trials?

Design quality and proper conduct are essential for protecting participants and generating credible results. When a trial is inadequately designed or poorly carried out, participant safety can be put at risk because risk assessments, monitoring, and safeguards may be insufficient. The results are prone to bias, insufficiently powered, or not applicable to the population, so the data produced are unreliable and cannot support valid conclusions. This wastes time, money, and the commitments of everyone involved—participants, investigators, and sponsors—since the study may have to be redone or cannot be trusted for decision-making. It also undermines confidence in the research enterprise and the efforts of those who contributed to the trial. In short, poor design and conduct threaten safety, data integrity, and efficiency. Note: These trials do not lead to faster approvals, do not guarantee robust data, and generally require appropriate or even increased monitoring to protect participants and ensure data quality.

Design quality and proper conduct are essential for protecting participants and generating credible results. When a trial is inadequately designed or poorly carried out, participant safety can be put at risk because risk assessments, monitoring, and safeguards may be insufficient. The results are prone to bias, insufficiently powered, or not applicable to the population, so the data produced are unreliable and cannot support valid conclusions. This wastes time, money, and the commitments of everyone involved—participants, investigators, and sponsors—since the study may have to be redone or cannot be trusted for decision-making. It also undermines confidence in the research enterprise and the efforts of those who contributed to the trial. In short, poor design and conduct threaten safety, data integrity, and efficiency.

Note: These trials do not lead to faster approvals, do not guarantee robust data, and generally require appropriate or even increased monitoring to protect participants and ensure data quality.

More practice questions